Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2024 Mar 20;20(6):872. doi: 10.1200/OP.24.00154

Erratum: Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2–Expressing Metastatic Breast Cancer

PMCID: PMC11556847  PMID: 38507668

The article by Rugo et al entitled “Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2–Expressing Metastatic Breast Cancer” (JCO Oncology Practice 10.1200/OP.22.00480) was published online May 19, 2023, with an error.

Dr Heather Moore's middle initial was incorrectly provided and should have been, “Heather N. Moore.”

This has been corrected as of March 20, 2024. The authors apologize for the error.


Articles from JCO Oncology Practice are provided here courtesy of Wolters Kluwer Health

RESOURCES